Shuai Xu,1– 5,* Yiyao Zeng,1,2,* Xin Tan,1,2 Ge Zhang,3– 5 Anchen Xu,1,2 Huimin Fan,6 Fengyi Yu,7 Zhen Qin,3– 5 Yahui Song,6 Yufeng Jiang,1,2 Xiangyu Wang,1,2 Duoduo Zhang,8 Yuxin Nong,1,2 Dede Lian,9 Junnan Tang,3– 5 Yafeng Zhou1,2 ...
Xu S+15 more
doaj
Cardiovascular-Kidney-Metabolic Syndrome, Special Article: Atatürk's Heart Disease. [PDF]
Erol Ç.
europepmc +1 more source
CardioPulse ArticlesPioneers in CardiologyMichel Haissaguerre MDThe rise of the ESC Council on Cardiovascular Nursing and Allied ProfessionsEuropean Society of Cardiology launches registry on infective endocarditisDo as I say,andas I doLeadership and management in cardiovascular medicine [PDF]
openalex +1 more source
ABSTRACT Background Despite the emergence of the transcaval (TCv) access route for transcatheter aortic valve implantation (TAVI) in the treatment of patients with hostile iliofemoral anatomy, the number of patients reported in clinical series of TCv TAVI has been relatively small (< 500 published cases). We assessed procedural and clinical outcomes in
Conor J. Doyle+6 more
wiley +1 more source
Retractions and Withdrawals in Clinical Cardiovascular Literature: Analysis of the Retraction Watch Database. [PDF]
Bhat V+4 more
europepmc +1 more source
Appropriateness of referrals for single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in Iran [PDF]
Gholamrezanezhad, A.+2 more
core
Breaking the Barrier: Unraveling the No‐Reflow Phenomenon in Cardiovascular Medicine
ABSTRACT The no‐reflow phenomenon is a stubborn and often devastating complication in cardiovascular medicine, where blood flow is restored to an artery, yet the microvasculature remains unresponsive. First identified in 1967, this phenomenon has haunted clinicians and researchers alike, particularly in the context of acute myocardial infarction (AMI).
Stephanie Howes+9 more
wiley +1 more source
President's page: The American College of cardiology and world cardiovascular medicine
openaire +2 more sources
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee+3 more
wiley +1 more source